Condensed Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended				6 Months Ended		12 Months Ended
	Jun. 30, 2025	Mar. 31, 2025	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2025	Jun. 30, 2024	Dec. 31, 2024
Operating activities
Net loss	$ (12,725)	$ (40,455)	$ (61,925)	$ 61,022	$ (53,180)	$ (903)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Non-cash loss on extinguishment of debt	0		53,235		0	53,235
Non-cash royalty revenue					(24,061)	(7,531)
Paid-in-kind interest on long-term debt					4,406	0
Depreciation expense					53	10
Amortization of debt issuance costs and discounts					1,519	879
Non-cash interest expense related to the revenue interest liability					0	21,569
Non-cash interest expense related to the royalty sale liability					26,363	0
Stock-based compensation expense					5,134	6,166
Changes in assets and liabilities:
Accounts receivable					(27,604)	(11,866)
Prepaids and other assets					(15,718)	(6,275)
Deferred revenue					13,795	(4,730)
Inventories					(19,975)	(18,846)
Other long-term liabilities					7,436	0
Accounts payable					30,462	15,898
Other accrued liabilities					(2,680)	(983)
Net cash (used in) provided by operating activities					(54,050)	46,623
Investing activities
Purchase of property and equipment					0	(150)
Net cash (used in) investing activities					0	(150)
Financing activities
Payments on revenue interest liability					0	(5,832)
Repurchase of revenue interest liability					0	(343,750)
Proceeds from royalty sale liability					0	304,656
Proceeds from issuance of common stock, net of issuance costs					0	90,672
Proceeds from issuance of common stock from ATM program, net of issuance costs					2,850	0
Proceeds from exercise of common stock options					0	29
Proceeds from exercise of warrants, net of issuance costs					0	14,808
Payment of issuance costs					(7,500)	0
Net cash (used in) provided by financing activities					(4,650)	60,583
Net (decrease) increase in cash and cash equivalents					(58,700)	107,056
Cash and cash equivalents at beginning of period		$ 144,761		$ 82,248	144,761	82,248	$ 82,248
Cash and cash equivalents at end of period	$ 86,061		$ 189,304		86,061	189,304	$ 144,761
Supplemental disclosure of cash flow information:
Common stock issuance costs not yet paid					92	0
Royalty sale issuance costs not yet paid					0	9,626
Purchase of property and equipment not yet paid					0	167
Non-cash right of use asset					$ 20	$ 84